Browsing ICR Divisions by subject "Treatment switch"
Now showing items 1-1 of 1
Interrogating Metastatic Prostate Cancer Treatment Switch Decisions: A Multi-institutional Survey. (2018-03)BACKGROUND: Evaluation of responses to treatment for metastatic castration-resistant prostate cancer (mCRPC) remains challenging. Consensus criteria based on prostate-specific antigen (PSA) and clinical and radiologic ...